Scholarly Index
Kai W. Wucherpfennig
Dana-Farber Cancer Institute; 44,986 total citations; 349 total publications; best world rank #65
Dana-Farber Cancer Institute
44,986Total citations
349Total publications
99H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Immune Cell Function and Interaction | Lifetime | 157 | US 100 | 99.79 |
| Immunotherapy and Immune Responses | Lifetime | 153 | US 89 | 99.72 |
| T-cell and B-cell Immunology | Lifetime | 130 | US 84 | 99.73 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 223 | US 144 | 99.54 |
| CAR-T cell therapy research | Lifetime | 200 | US 125 | 99.30 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 581 | US 296 | 98.72 |
| Diabetes and associated disorders | Lifetime | 636 | US 246 | 97.66 |
| vaccines and immunoinformatics approaches | Lifetime | 648 | US 296 | 93.69 |
| Immune Cell Function and Interaction | 2021-2025 | 65 | US 33 | 98.84 |
| CAR-T cell therapy research | 2021-2025 | 189 | US 104 | 98.68 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 552 | US 208 | 97.86 |
| T-cell and B-cell Immunology | 2021-2025 | 361 | US 158 | 91.50 |
| Immunotherapy and Immune Responses | 2021-2025 | 933 | US 310 | 91.14 |
| Chemokine receptors and signaling | 2021-2025 | 932 | US 209 | 46.72 |